CLDF Title
Contact Us | Bookmark
  HBV   HCC   HCV   HE   NASH   PBC   THROMBOCYTOPENIA
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights

Featured Programs
      IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Roche buys U.S. biotech Jecure in race for liver disease drugs
11-27-2018
REFILE-Alcohol consumption cutoffs do not identify gastric bypass patients with alcohol problems
11-26-2018
Alcohol consumption cutoffs do not identify gastric bypass patients with alcohol problems
11-26-2018
In half of hepatitis C patients, DAA treatment can shortened to 6 weeks
11-23-2018
Screening, brief behavioral counseling can reduce unhealthy alcohol use
11-13-2018
View Complete News Library
 
 
View all Congresses
 
 
 
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis?
 
Management of Recurrent and De Novo NAFLD/NASH after Liver Transplantation
 
Validation of Serum Test for Advanced Liver Fibrosis in Patients with Nonalcoholic Steatohepatitis
 
BET Inhibition Improves NASH and Liver Fibrosis
 
Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
 
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
 
What is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats
 
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
 
Management of chronic hepatitis B during pregnancy
 
Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection
 
Combination of entecavir/ peginterferon alfa-2a in children with HBeAg-positive immune tolerant chronic hepatitis B virus infection
 
Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues
 
The actual management of Hepatitis B and Hepatitis C in children
 
Glecaprevir/Pibrentasvir in Patients with Chronic HCV Genotype 3 Infection: An Integrated Phase 2/3 Analysis
 
National Trends in Liver Transplantation in Older Adults
 
 
Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus (HCV) Management in Opioid Use Disorder Patients on Methadone
 
Improved Liver Transplant Waitlist Mortality and Lower Risk of Disease Progression Among Chronic Hepatitis C Patients Awaiting Liver Transplantation After the Introduction of Direct Acting Antiviral Therapies in the United States
 
Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis Cvirus infection
 
The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease
 
Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children
 
Care of Incarcerated Patients
 
Telementoring for hepatitis C treatment in correctional facilities
 
Future Trends in Demand for Liver Transplant: Birth-Cohort Effects among Patients with NASH and HCC
 
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
 
Systemic therapy for hepatocellular carcinoma: beyond sorafenib
 
Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
 
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib
 
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients With Advanced Hepatocellular Carcinoma
 
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
 
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
 
 
Hyperammonemia in Hepatic Encephalopathy
 
Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials
 
Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: A systematic review
 
Frailty, Psychoactive Medications, and Cognitive Dysfunction are Associated with Poor Patient-Reported Outcomes in Cirrhosis
 
Hepatic encephalopathy: Sometimes more portal than hepatic
 
Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)
 
Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review
 
A Novel Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of NAFLD and HCC
 
Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
 
Non-alcoholic fatty liver disease: a narrative review of genetics
 
Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis
 
Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis
 
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
 
Nonalcoholic Fatty Liver Disease
 
 
          View All Abstracts  
  Line  
                               
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
OTHER
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.